The cytoskeletal filament vimentin is inherent to the endothelial phenotype and is critical for the proper function of endothelial cells in adult mice. It is unclear, however, if the presence of vimentin is necessary during differentiation to the endothelial phenotype. Here we evaluated gene and protein expression of differentiating wild type embryonic stem cells (WT ESCs) and vimentin knockout embryonic stem cells (VIM −/− ESCs) using embryoid bodies (EBs) formed from both cell types. Over seven days of differentiation VIM −/− EBs had altered morphology compared to WT EBs, with a rippled outer surface and a smaller size due to decreased proliferation. Gene expression of pluripotency markers decreased similarly for EBs of both cell types; however, VIM −/− EBs had impaired differentiation towards the endothelial phenotype. This was quantified with decreased expression of markers along the specification pathway, specifically the early mesodermal marker Brachy-T, the lateral plate mesodermal marker FLK1, and the endothelial-specific markers TIE2, PECAM, and VE-CADHERIN. Taken together, these results indicate that the absence of vimentin impairs spontaneous differentiation of ESCs to the endothelial phenotype in vitro.
Vascular endothelial cells are important for tissue engineering and regenerative medicine therapies designed to treat vascular pathologies. Applications include the endothelialization of vascular grafts to prevent thrombosis, vascularization of tissue engineered organs, or augmentation of vessel growth in ischemic tissue after injury. Such therapies, however, require large numbers of endothelial cells, which are difficult to obtain as primary cells or with stable phenotypic expansion. Pluripotent stem cells, including embryonic stem cells, have the capacity to self-renew and differentiate to all phenotypes in the body and are therefore an attractive source for cell-based therapies.
For the success of vascular therapies, stem cell-derived endothelial cells must recapitulate the essential attributes of mature endothelial cells. During normal physiology, endothelial cells (ECs) in vivo are exposed to blood flow-induced shear stress. A proper response to this mechanical cue is pivotal for maintaining the physiologic endothelial phenotype. Nitric oxide and sodium regulation, as well as cytoskeletal alignment, are regulated in vivo by blood flow 1 . Multiple cytoskeletal proteins are also remodeled in vitro as part of the endothelial mechanoresponse. For example, actin stress fibers that span the cell realign in the direction of flow 2 and the network of vimentin molecules undergo micrometer and nanometer level displacements 3, 4 in normal ECs exposed to shear stress. A robust cytoskeletal infrastructure is therefore an inherent trait of functional ECs.
The cytoskeleton network is composed of three categories of structural proteins: microtubules, microfilaments, and intermediate filaments. Vimentin, an intermediate filament with a diameter of approximately 10 nm, is thought to provide mechanical integrity and structural support to cells 5 . While expressed in a variety of mesenchymal cell types, vimentin is a critical player in the physiologic endothelial mechanoresponse and is inherent to the endothelial phenotype 4, 6 . In knockout animals, the loss of vimentin results in viable mice but has been implicated in pathological vascular function. Vimentin − /− mice compared to the wild type have been observed to have a smaller carotid artery 7 , decreased flow-induced arterial dilation 7 , delayed arterial remodeling 8 , and increased permeability of the endothelial barrier 9 . Thus, the presence of vimentin is necessary for proper endothelial function in adult mice.
Vimentin is inherent to fully differentiated ECs, yet it is unclear if the presence of vimentin is necessary during in vitro differentiation. Here we formed embryoid bodies from both wild type embryonic stem cells and vimentin knockout embryonic stem cells to study differentiation towards the endothelial phenotype. Over 7 days of Scientific RepoRts | 6:30814 | DOI: 10.1038/srep30814 spontaneous differentiation, the wild type cells increased expression of endothelial specific markers by 4-90X, which was a ~5-fold greater change than that observed with the vimentin knockout cells. Thus, the lack of vimentin in embryonic stem cells resulted in impaired endothelial differentiation in vitro.
Results
Pluripotency of Vimentin −/− Stem Cells. Vimentin knockout embryonic stem cell (VIM − /− ESC) and wild type embryonic stem cell (WT ESC) samples were morphologically similar when cultured on feeder layers (Fig. 1a) . Both cell types formed colonies with refractive edges containing tightly compact cells (Fig.1a  arrows) , typical of pluripotent stem cells. WT ESCs and VIM − /− ESCs were also evaluated for gene (Fig. 1b ) and protein (Fig. 1c) expression of pluripotency markers. Gene expression levels of pluripotency markers (Nanog, Oct4, Sox2) were similar for both cell types with no significant differences detected for any of the three genes (Nanog: p = 0.158; Oct4: p = 0.558; Sox2: p = 0.233). Likewise, flow cytometry analysis revealed that both VIM − /− ESC and WT ESC populations had largely similar levels of protein expression of the three pluripotency markers. Compared to WT ESCs, VIM − /− ESCs had a wider distribution of expression intensities for NANOG and OCT3/4, though both populations were > 90% positive compared to their negative controls. Both cell types were also 98% positive for SOX2 (compared to negative controls) and had similar expression profiles on the population level. Thus, both WT ESCs and VIM − /− ESCs had similar morphologies as well as similar expression levels of pluripotency markers. Taken together, these results indicate that both WT ESCs and VIM − /− ESCs have a similar state of pluripotency during in vitro culture.
Embryoid Body Morphology and Proliferation. Embryoid Bodies (EBs) were generated from either vimentin knockout or wild type embryonic stem cells to evaluate differences during spontaneous differentiation. VIM − /− ESCs failed to form EBs under standard rotary conditions ( Supplementary Fig. S1 ). Consequently, physical aggregation with microwells was used to create EBs from VIM − /− ESCs. WT EBs were similarly generated to allow for direct comparison. After 1 day in the microwells, both wild type and vimentin knockout cells aggregated to form EBs (WT EBs and VIM − /− EBs, respectively) that remained intact upon removal from the microwells (Fig. 2a) . VIM − /− EBs agglomerated under rotary culture ( Supplementary Fig. S1 ), so all EBs were instead cultured under static conditions. Size analysis of phase images revealed that EBs generated from either cell type increased in size over the culture period ( Fig. 2a,b ; p time < 0.001). Compared to WT EBs, however, VIM − /− EBs had markedly lower growth rates leading to smaller EBs (p cell < 0.001 and p cellxtime < 0.001). These findings were corroborated by immunohistochemical analysis of samples with Ki67, a nuclear marker of proliferation (Fig. 2c ). While Day 6 WT EB samples had many cells that stained intensely for Ki67, time matched VIM − /− EBs had little to no detectible expression. Thus both cell types were able to form EBs under physical aggregation, though vimentin − /− cells proliferated less during differentiation and resulted in smaller embryoid bodies.
The morphological properties of the EBs from the different cell types were dissimilar. Phase images indicated that WT EBs established a smooth outer layer, while VIM − /− EBs had a less well defined border (Fig. 2a) . Immunohistochemical analysis for the epithelial cell-cell adhesion molecule (ECAD) showed that WT EBs had some staining in the interior (Fig. 3, star) , but predominantly had a continuous layer of expression at the periphery (Fig. 3) . VIM − /− EBs also had expression at the periphery, however it was discontinuous (Fig. 3, arrow) . Similarly, higher resolution SEM images of intact EBs showed that WT EBs had a smooth outer layer, while the surfaces of VIM − /− EBs were rippled due to more rounded cells. Images of fractured EBs, however, showed no apparent differences in cell organization in the interior of the EBs. These results indicate that WT EBs form Pluripotency in Embryoid Bodies. Change in pluripotency of WT EBs and VIM − /− EBs was evaluated by gene expression of Nanog, Oct4, and Sox2 (Fig. 4) . In the WT EBs, Nanog expression generally trended downward with differentiation from Day 0 to Day 7. Expression in VIM − /− EBs followed similar trends, with no detected difference between the two cell types. Similarly, expression of Oct4 and Sox2 in EBs of each cell type decreased significantly over time (Oct4: p time < 0.001; Sox2: p time < 0.05) with no differences observed between cell types. Thus, both wild type and vimentin − /− cells similarly lose expression of pluripotency markers during differentiation as embryoid bodies.
Early Mesodermal Differentiation. Evaluation of early mesodermal commitment was evaluated with gene expression of Brachy-T (Fig. 5a ). WT EBs expressed Brachy-T transiently with levels peaking at Day 4, which is consistent with previous findings [10] [11] [12] . Overall, Brachy-T expression in VIM − /− EBs was markedly and significantly (p cell < 0.001) lower compared to the wild type samples throughout the culture period. In comparing each timepoint, post-hoc Tukey tests indicated that VIM − /− EBs had significantly (* * p < 0.01) lower expression of Brachy-T compared to WT EBs specifically for Days 2 to 4. A slight elevation in expression at Days 5-7 was observed in VIM − /− EBs, but levels still remained low. Thus, overall VIM − /− EBs had a decreased mesodermal commitment over 7 days of differentiation compared to WT EBs.
Differentiation to specific mesodermal plates was evaluated with Meox1 and Flk1, markers for the paraxial and lateral plate mesoderm, respectively (Fig. 5a ). Meox1 expression in EBs from each cell type had a similar and significant (p time < 0.001) increase over 7 days of culture. Post hoc analysis did detect, however, a significantly higher expression in WT cells compared to VIM − /− at Day 7 (* p < 0.05). In evaluating Flk1, expression in WT EBs increased in a sigmoidal pattern to 80X of initial values over the 7 days of culture. Overall expression of Flk1 in VIM − /− EBs was statistically (p cell < 0.001) lower compared to those WT controls; initial Flk1 expression levels were similar in both cell types until Day 3 after which levels in WT EBs increased significantly (* p < 0.05, * * p < 0.01) more than in VIM − /− EBs. These large differences in Flk1 gene expression were corroborated with visualization and quantification of protein expression (Fig. 5b,c) . At Days 6, 8, and 10, WT EB samples all showed FLK1 protein expression both along the outer edge and in the interior of the EBs. Expression in the middle of the EBs was patchy with some areas of concentrated expression compared to regions with less visible staining. VIM − /− EBs, on the other hand, had very little overall FLK1 expression, with the limited expression observable at both the periphery and the interior. Flow cytometry analysis further revealed that protein expression after 10 days of differentiation in VIM− /− EBs was significantly lower than that in time matched WT EBs (p < 0.01: 58 ± 4.8% vs 78 ± 1.7%, respectively). Thus, both gene and protein analysis indicate that VIM − /− EBs compared to WT EBs have decreased specification to overall mesoderm and markedly impaired differentiation to the lateral plate mesoderm.
Endothelial Differentiation. Endothelial differentiation, which arises from the lateral plate mesoderm, is robustly observed in embryoid bodies during spontaneous differentiation. Over 7 days of differentiation, gene expression in WT EBs increased significantly (p < 0.001 for all) for the endothelial markers Tie2, Pecam, and VE-Cadherin by 14X, 4X, and 90X, respectively (Fig. 6a) . In WT EBs, Tie2 and Pecam expression, similar to Flk1 expression, increased in a sigmoidal pattern with relatively low initial levels followed by markedly higher subsequent levels. Tie2 expression for Days 5-7 were similar to each other but significantly (p < 0.001) higher than the expression for all of the initial 4 days. Similarly for Pecam, gene expression for both Day 6 and 7 were significantly (p < 0.05) higher than all levels during the initial 3 days. In contrast, gene expression of Tie2 and Pecam in the VIM − /− EBs was not sigmoidal but instead remained relatively low throughout differentiation. Tie2 gene expression increased significantly (p < 0.05) over time but never rose above the initial levels found in the WT EBs and no significant differences were detected for Pecam expression over time in VIM − /− EBs. Gene expression of VE-Cadherin, a marker of the mature endothelial phenotype, increased steadily over 7 days of differentiation in WT EBs. Expression levels in VIM − /− EBs were consistently lower compared to time matched wild type controls and reached only 35% of the control value at Day 7. Overall, there was a statistically significant (p cell < 0.001) difference in gene expression between the cell phenotypes for all three endothelial markers.
Expression at the protein level for these endothelial differentiation markers was evaluated in histology samples of Day 6, 8, and 10 EBs and with flow cytometry at Day 10. At Day 6 ( Supplementary Fig. S4 ), WT EBs had some expression of the early endothelial marker TIE2, but almost no expression of PECAM or VE-CADHERIN. By Days 8 and 10 ( Fig. 6b) , however, WT EBs had acquired robust expression of all three endothelial proteins throughout large regions of the cell clusters. In contrast, VIM − /− EBs had very little expression of endothelial proteins over the 10 days of differentiation. In those samples at Day 8 and 10, a modest amount of TIE2 expression was visible in the interior of some EBs, while traces of PECAM were observed at the outer edges of the cell clusters. VE-CADHERIN, a later protein marker of the endothelial phenotype, was not detected in any of the VIM − /− EBs. Furthermore, quantitation using flow cytometry of Day 10 EBs revealed a significantly lower percentage of cells positively expressing TIE2 in VIM − /− EBs compared to WT EBs (15 ± 1.6% compared to 38 ± 1.5%, p < 0.001). Similarly, VIM − /− EBs, compared to WT EBs, had a reduced percentage of cells expressing PECAM (6 ± 1.8% compared to 20 ± 1.0%, p < 0.01) and VE-CADHERIN (4 ± 0.7% compared to 9 ± 0.6%, p < 0.01). Thus VIM − /− EBs, in contrast to WT EBs, have significantly lower gene or protein expression of endothelial markers.
Discussion
Vimentin knockout embryonic stem cells (VIM − /− ESCs) were similar in pluripotency to wild type embryonic stem cells (WT ESCs), yet their capacity to form and differentiate as embryoid bodies (EBs) was markedly impaired. Gene and protein expression of pluripotency markers in undifferentiated cells were similar for both phenotypes. For the VIM − /− ESCs, however, EB formation required an initial 24 hours of physical aggregation prior to static suspension culture. Over seven days of differentiation, the VIM − /− EBs displayed an altered morphology compared to wild type controls, with a smaller size due to decreased proliferation and a rippled outer surface with disrupted ECAD expression. While gene expression of pluripotency markers decreased similarly for EBs of both cell types, VIM − /− EBs had impaired differentiation towards the endothelial phenotype. This was observed with decreased expression of markers along the specification pathway, specifically the early mesodermal marker Brachy-T, the lateral plate mesodermal marker FLK1, and the endothelial-specific markers TIE2, PECAM, and VE-CADHERIN. Quantitatively, over 7 days of spontaneous differentiation the wild type cells increased expression of endothelial specific markers by 4-90X, which was a ~5-fold greater change than that observed with the vimentin knockout cells. These same effects were not observed in differentiation to other mesodermal phenotypes, including cardiovascular and orthopedic, which also express vimentin ( Supplementary Fig. S3 ). Thus, these results indicate that the absence of vimentin impairs differentiation in the embryoid body model of ESCs to the endothelial phenotype.
Knockout mice lacking vimentin initially were deemed phenotypically normal 13 , however subsequent analysis of these animals has shown differences in vascular remodeling and wound healing processes. Vimentin − /− mice have delayed arterial remodeling 8 and decreased flow-induced arterial dilation 7 . Specifically in the endothelial cells of these knockout mice, vimentin has been shown to be important in regard to the integrity of the vascular endothelium 14 . Similar results were found in an in vitro study where disruption of vimentin in an endothelial cell monolayer led to increased permeability 9 . While these previous studies reveal that the absence of vimentin can affect vascular function, the studies performed here show that vimentin is critical in differentiation towards the endothelial phenotype in vitro.
This study found that cells lacking vimentin had impaired spontaneous differentiation in vitro toward the endothelial phenotype. Endothelial differentiation in the absence of vimentin is possible, however, during development 13 and teratoma formation 15 17 , cell-matrix adhesion 16, 18 , and hemodynamic forces 19 . Additional directed differentiation studies in vitro may be useful to identify the additional chemical or physical factors that compensate for the absence of vimentin.
The lack of vimentin leads to decreased contractile capabilities and migration, as has been shown through decreased migration of fibroblasts 20 , reduced compaction of collagen gels 20 , and impaired wound healing in vimentin − /− mice 21, 22 . Intracellular contraction that results in migration is also important during development, including the epithelial to mesenchymal transition (EMT) of gastrulation 23 . Cells in the inner cell mass, from which pluripotent ESCs are derived, differentiate as they form the ectodermal, mesodermal, and endodermal germ layers. In particular, cells of the mesoderm need the cytoskeletal infrastructure to become motile in order to penetrate the primitive streak on the ectoderm and migrate to fill the space below. This is consistent with our own previous in vitro studies in which we found that pluripotent ESCs have little cytoskeleton 24 and that cytoskeletal expression increases markedly with differentiation 24, 25 . Here we have begun to understand the role of the cytoskeleton in differentiation in that vimentin is pivotal to differentiate ESCs to the mesodermal lineage and the endothelial phenotype in vitro.
Vimentin has also been implicated in cellular interactions with the external microenvironment. We found that VIM − /− cells have altered cell-cell interactions compared to wild type controls, as evidenced by a failure to aggregate to form clusters during suspension-induced EB formation, as well as disrupted ECAD expression and a rippled surface in the outer layer of physically-aggregated EBs. Studies by others have shown that focal contacts in vimentin knockout cells have a disrupted architecture 20 , are of smaller size 26 , and have destabilized adhesion to the extracellular matrix 18 . It has also been shown that vimentin has a functional role in adhesive strength through its interactions with plectin 27 , a cytoplasmic cross-linker connecting intermediate filaments to microtubules, microfilaments, and membrane adhesion proteins 28 . These studies, taken together with the findings presented here, provide further evidence that vimentin has a role in the transmembrane protein complexes that regulate adhesion to adjacent cells and matrix proteins.
Mechanical forces have been shown to regulate stem cell fate including the process of differentiation. For example, our group has shown that embryonic stem cells (ESCs) exposed to fluid shear stress differentiate toward the mesodermal lineage 12 and specifically to the endothelial phenotype 29 . The cytoskeleton is known to regulate the cellular response to mechanical forces and remodel during differentiation 25 and dedifferentiation 24 . While these studies investigated the role of vimentin during spontaneous differentiation, what has yet to be determined is the role of vimentin during directed differentiation in response to mechanical cues.
Vimentin is a structural protein that may also play a role in intracellular signaling. Small precursor subunits 30, 31 of vimentin have been shown to travel intracellularly along microtubules with the aid of kinesin 30, 32 and dynein 33 . These subunits, in addition to integrating with the overall vimentin network, can also aid in signaling processes 34 . Specifically, vimentin subunits may directly interact with ERK to modulate signaling during EMT 35 and to transport phosphorylated ERK1/2 to the nucleus of cells after nerve injury 36 . Thus, it is possible that vimentin can modulate differentiation by regulating biochemical signaling cascades.
Vimentin may also play a role in cellular mechanics and the mechanoresponse directly or through its interaction with other cytoskeletal proteins. Vimentin is known to link to both microtubules (MTs) and microfilaments (MFs) 37 . Furthermore, the tail end of vimentin can link directly to MFs or to actin containing structures 38, 39 . These interactions may account for observed alterations in MT patterning and polarity in vimentin knockout fibroblasts 40 . Conversely, the vimentin network is disrupted when MT or MF networks depolymerize 41 . These changes in cytoskeletal organization lead to changes in cellular mechanical properties. In the case of vimentin, its absence has been shown to increase deformability 42 and shear modulus 43 , as well as increase cell viscosity and decrease resistance to compression 44 . Hence, the absence of vimentin leads to changes in cytoskeletal organization which alters the overall mechanical properties of the cell and therefore its mechanoresponse.
Vimentin stem cells as a cell source requires a thorough understanding of the differentiation process. Using knockout ESCs, we found that the absence of vimentin impairs spontaneous endothelial differentiation in vitro and have furthered our understanding of the regulators of differentiation. This type of study is necessary for the rational design of efficient differentiation protocols to generate clinically-relevant numbers of cells for tissue engineering and regenerative medicine applications.
Methods
Embryonic Stem Cell Culture. Vimentin knockout mouse embryonic stem cells (VIM − /− ESCs; strain C57BL/6; Vim_AF3 from the KOMP Repository) and wild type mouse embryonic stem cells (WT ESCs; strain 129; ESD3 cells from ATCC ™ ) were expanded as previously described 12, 25, 29, 45 . Briefly, ESCs were initially expanded on a mitotically inactivated feeder layer and then expanded for at least one passage on gelatin-coated plastic in culture medium, which consisted of Dulbecco's Modification of Eagles Medium supplemented with 15% ES-qualified fetal bovine serum (Invitrogen), 2 mM L-glutamine, 0.1 mM non-essential amino acids, 0.1 mM beta-mercaptoethanol, 1,000 U/ml Leukemia Inhibitory Factor (LIF; ESGRO ® from EMD Millipore) and antibiotics.
Embryoid Body Differentiation. WT ESCs and VIM − /− ESCs were spontaneously differentiated as embryoid bodies (EBs) in 3D suspension culture, referenced in these studies as WT EBs and VIM − /− EBs, respectively. VIM − /− ESCs did not spontaneously aggregate in suspension culture ( Supplementary Fig. S1 ), requiring that EBs be generated using commercially available microwells (AggreWell ™ ) that induce physical aggregation 46, 47 . Both types of ESCs were dissociated and seeded at a density of 800 cells/microwell for 24 hours. EBs were then transferred to agar-coated non-tissue culture dishes and maintained for up to 10 days in medium without LIF. Medium and dishes were changed using gravity separation every 24 hours after the third day. Vimentin expression remained low in VIM − /− EBs over the culture duration, validating the knockout of vimentin expression (Supplementary Fig. S2 ).
Morphological Assessment. Phase contrast microscopy and scanning electron microscopy (SEM) were used to determine the morphology of pluripotent cell colonies and EBs. EB size was evaluated by cross sectional areas as determined using ImageJ software and phase images of EBs generated from each cell type (n = 50 EBs per group). Details of EB topology were visualized using SEM. EBs for this analysis were fixed in 2.5% glutaraldehyde and 1% osmium tetroxide/0.1 sodium cacodylate solution (Sigma Aldrich ® ). Samples were then fractured, dehydrated, sputter-coated with carbon, and assessed on a Hitachi 4800 system. Gene Expression. Samples were evaluated for gene expression as described previously 12 . For each sample, RNA was isolated (Qiagen), converted into cDNA (Invitrogen), and analyzed using standard real-time PCR with SYBR ® Green on a StepOnePlus ™ PCR System (Applied Biosystems). Primers were designed to assess pluripotency (Homeobox Transcription Factor Nanog: Nanog; Octamer-Binding Protein: Oct4; Sex Determining Region y-Box 2: Sox2), mesodermal commitment (T-homeobox domain: Brachy-T), mesodermal differentiation (mesenchyme homeobox 1: Meox1; vascular endothelial growth factor receptor 2: Flk1) and endothelial differentiation (Tyrosine Kinase: Tie2; Platelet/Endothelial Cell Adhesion Molecule: Pecam; Cadherin 5, Type 2 Vascular Cadherin: VE-Cadherin). Gene expression levels were determined using standard curves and reported normalized to glyceraldehyde-3-phosphate dehydrogenase (Gapdh).
Protein Expression. Standard protocols for immunohistochemistry and flow cytometry were used to determine protein expression as described previously 12, 48 . EBs were fixed in 4% formaldehyde, paraffin embedded, and sectioned (6 μ m slices). Sample sections were deparaffinized, heat treated for antigen retrieval, blocked for non-specific binding with serum, and then stained with primary and secondary antibodies, as well as HOECHST 33258 as a nuclear counterstain. Primary antibodies used were specific for Ki67 (Abcam), α -E-Cadherin (ECAD; R&D Systems ® ), FLK1 (Santa Cruz), TIE2 (PE-conjugated, Abcam), PECAM (Santa Cruz), VE-CADHERIN (Santa Cruz). Secondary antibodies were conjugated with AF488 (Molecular Probes, Eugene, OR) and samples were visualized with a Nikon A1 confocal microscope.
Protein expression was quantified using flow cytometry. EBs were dissociated using StemPro ® Accutase ® (Life Technologies) and mechanical trituration. Cell solutions were then fixed in 4% formaldehyde, permeabilized using 0.5% triton-X (Sigma), blocked with serum, and stained with primary and secondary antibodies (listed above). Primary antibodies used were specific for NANOG (Abcam), OCT3/4 (Santa Cruz), SOX2 (FITC-conjugated, eBiosciences), FLK1 (Santa Cruz), TIE2 (PE-conjugated, Abcam), PECAM (Santa Cruz), VE-CADHERIN (Santa Cruz). For each sample, the cells were considered positive if expression was above 99% of the matched secondary only control populations. An Attune Acoustic Focusing Cytometer (Applied Biosystems) was used for fluorescence detection.
Statistical Analysis. Quantitative data are represented as mean ± SEM for n = 3 independent trials for gene expression analysis, n = 50 for EB size quantification analysis, and n = 4 for protein expression analysis. Direct comparisons between WT ESCs and VIM − /− ESCs were analyzed using two-tailed Student's t-tests. The kinetic data was analyzed with a 2-way ANOVA using a post hoc Tukey test as appropriate for comparisons on time, cell type, and their interaction. Differences were considered statistically significant for p-values < 0.05.
